IntelGenx’ three technology platforms have been designed to address
the challenges commonly encountered in oral drug delivery, like
first-pass metabolism, gastrointestinal side effects, or incomplete
absorption of the drug in the GI tract. Our technologies are broadly
applicable and have the ability to improve the performance of a wide
variety of existing pharmaceutical compounds.
IntelGenx has the capability to tailor drug release profiles and target specific absorption sites, thus unlocking the full therapeutic potential of a drug.
Our current technology portfolio includes the following Oral Drug Delivery Systems: